Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage

World Neurosurgery

Volumn 73, Issue 6, 2010, Pages 675-682

  Yamamoto, Takuji ^a   Esaki, Takanori ^a   Nakao, Yasuaki ^a   Mori, Kentaro ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

Cisternal irrigation; Interleukin 6; Matrix metalloproteinase 9; Subarachnoid hemorrhage; Tissue plasminogen activator; Vasospasm

Indexed keywords

RINGER LACTATE SOLUTION; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOT; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE; BRAIN ANGIOGRAPHY; COMPLICATION; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; INTRACRANIAL THROMBOSIS; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; STANDARDS; SUBARACHNOID SPACE; SURGICAL EQUIPMENT; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

AGED; CEREBRAL ANGIOGRAPHY; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; SURGICAL INSTRUMENTS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 77957792028     PISSN: 18788750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.wneu.2010.04.002     Document Type: Review

References (28)

1. M. Castellanos, R. Leira, J. Serena, M. Blanco, S. Pedraza, J. Castillo, and A. Davalos Plasma cellularfibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke Stroke 35 2004 1671 1676
2. A.S. Dumont, R.J. Dumont, M.M. Chow, C.L. Lin, T. Calisaneller, K.F. Ley, N.F. Kassell, and K.S. Lee Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation Neurosurgery 53 2003 123 135
3. J.M. Findlay, N.F. Kassell, B.K. Weir, E.C. Haley, G. Kongable, T. Germanson, L. Truskowski, W. Alves, R.O. Holness, N.W. Knuckey, H. Yonas, G.K. Steinberg, M. West, H.R. Winn, and G. Ferguson A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm Neurosurgery 37 1995 168 178
4. J.M. Findlay, B.K. Weir, D. Steinke, T. Tanabe, P. Gordon, and M. Grace Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH J Neurosurg 69 1988 723 735
5. J.A. Frontera, A. Fernandez, J.M. Schmidt, J. Claassen, K.E. Wartenberg, N. Badjatia, E.S. Connolly, and S.A. Mayer Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage Neurosurgery 66 2010 35 41
6. H. Kinouchi, K. Ogasawara, H. Shimizu, K. Mizoi, and T. Yoshimoto Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage Neurol Med Chir (Tokyo) 44 2004 569 575
7. N. Kodama, T. Sasaki, M. Kawakami, M. Sato, and J. Asari Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage Outcome in 217 patients Surg Neurol 53 2000 110 117
8. T. Mathiesen, B. Andersson, A. Loftenius, and H. von Holst Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage J Neurosurg 78 1993 562 567
9. K. Mizoi, T. Yoshimoto, A. Takahashi, S. Fujiwara, K. Koshu, and T. Sugawara Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator J Neurosurg 78 1993 430 437
10. J. Montaner, C.A. Molina, J. Monasterio, S. Abilleira, J.F. Arenillas, M. Ribo, M. Quintana, and J. Alvarez-Sabin Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 107 2003 598 603
11. K. Mori, M. Miyazaki, Y. Hara, Y. Aiko, T. Yamamoto, and Y. Nakao Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage J Neurosurg 110 2009 73 78
12. K. Mori, M. Miyazaki, J. Iwata, T. Yamamoto, and Y. Nakao Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat Neurosurg Rev 31 2008 197 203
13. E. Moriyama, Y. Matsumoto, T. Meguro, S. Kawada, S. Mandai, Y. Ghoda, and M. Sakurai Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage Neurol Med Chir (Tokyo) 35 1995 732 736
14. M. Ning, K.L. Furie, W.J. Koroshetz, H. Lee, M. Barron, M. Lederer, X. Wang, M. Zhu, A.G. Sorensen, E.H. Lo, and P.J. Kelly Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke Neurology 66 2006 1550 1555
15. J. Ohman, A. Servo, and O. Heiskanen Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 75 1991 197 201
16. S. Sasaki, S. Ohta, H. Kuwabara, and M. Shiraishi The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysm Acta Neurochir (Wien) 88 1987 87 94
17. T. Sasaki, N. Kodama, M. Kawakami, M. Sato, J. Asari, Y. Sakurai, K. Watanabe, T. Onuma, and T. Matsuda Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system Stroke 31 2000 1256 1262 (Pubitemid 30351242)
18. T. Sasaki, T. Ohta, H. Kikuchi, K. Takakura, M. Usui, H. Ohnishi, A. Kondo, H. Tanabe, J. Nakamura, K. Yamada, N. Kobayashi, and Y. Ohashi A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage Neurosurgery 35 1994 597 604
19. B. Schoch, J. Regel, M. Wichert, T. Gasser, L. Volbracht, and D. Stolke Analysis of intrathecal interleukin-6 as a potential predictive factor for vasospasm in subarachnoid hemorrhage Neurosurgery 60 2007 828 836
20. V. Seifert, D. Stolke, M. Zimmerman, and A. Feldges Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA): a prospective study Acta Neurochir (Wien) 128 1994 137 143
21. R. Sercombe, Y.R. Dinh, and P. Gomis Cerebrovascular inflammation following subarachnoid hemorrhage Jpn J Pharmacol 88 2002 227 249
22. M. Shibuya, Y. Suzuki, K. Sugita, I. Saito, T. Sasaki, K. Takakura, I. Nagata, H. Kikuchi, T. Takemae, H. Hidaka, and M. Nakashima Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage Results of a prospective placebo-controlled double-blind trial J Neurosurg 76 1992 571 577
23. G.K. Steinberg, M.A. Vanefsky, M. Marks, J.R. Adler Jr, and G.H. Koenig Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage Neurosurgery 34 1994 809 814
24. Y. Suzuki, M. Shibuya, S. Satoh, Y. Sugimoto, and K. Takakura A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage Surg Neurol 68 2007 126 131
25. M. Usui, N. Saito, K. Hoya, and T. Todo Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone Neurosurgery 34 1994 235 244
26. K. Yamada, S. Yoshimura, Y. Enomoto, H. Yamakawa, and T. Iwama Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage Br J Neurosurg 22 2008 649 653
27. J. Zabramski, R. Spetzler, K. Lee, S. Papadopoulos, E. Bovill, R. Zimmerman, and J. Bederson Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 75 1991 189 196
28. B. Zhang, S. Dhillon, I. Geary, W.M. Howell, F. Iannotti, I.N. Day, and S. Ye Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage Stroke 32 2001 2198 2202